In a recent review published in Immunity, researchers reviewed tumor-immunity cycle data.
FDA approves Takeda’s targeted therapy for advanced colon cancer
The FDA’s approval of Fruzaqla was based on its positive Phase III trials. Credit: Orawan Pattarawimonchai via Shutterstock. On 8 November, Takeda announced it had